Researchers from AMRA will present an abstract at the 60th annual European Association for the Study of Diabetes Meeting that emphasizes the link between adverse muscle composition and all-cause mortality in Type II Diabetes
Read MoreAMRA Medical continues to set the standard in MRI-based body composition analysis with their recently obtained EU MDR certificate (NB 2862) for the next-generation AMRA® Profiler 4
Read MoreAMRA expands footprint in kidney disease research with updated results from a study exploring various biomarkers’ potential in characterizing muscle composition’s role in chronic kidney disease progression and identifying at-risk patients
Read MoreSignificant findings from a recent AMRA imaging analysis study, which were presented last week at the 2024 European Congress on Obesity, glean insight into the role of adverse muscle composition in mortality risk in obesity
Read MoreResults from a randomized, double-blind trial in diabetes-free adults living with obesity and high cardiovascular disease risk showed that liraglutide was associated with a reduction in both muscle fat infiltration and prevalence of adverse muscle composition when compared to placebo
Read MoreThe comprehensive ACCESS-ESLD study aims to validate novel biomarkers and imaging techniques for screening of hepatocellular carcinoma and sarcopenia in liver cirrhosis patients using a rapid, non-invasive clinical surveillance methodology, powered by AMRA’s MRI-based body composition technology
Read More
